> Skip repeated content
photo of Robert F. Spiera, MD

Robert F. Spiera, MD

Rheumatology
phone icon

About Dr. Spiera

Dr. Spiera is the Director of the Scleroderma, Vasculitis, and Myositis Center at Hospital for Special Surgery, and a Professor of Clinical Medicine at Weill Cornell Medical College. He has been the principal investigator in several clinical trials and observational studies focusing on scleroderma and vasculitis. Dr. Spiera specializes in the treatment of various rheumatologic conditions including scleroderma, vasculitis, systemic lupus erythematosus, and Sjogren’s syndrome. He has authored over 150 publications relating to scleroderma, vasculitis, and other rheumatic diseases.

Profile Video

Departments

Specialized Centers

Scleroderma, Vasculitis & Myositis Center of Excellence

Special Expertise

Scleroderma
Vasculitis
Systemic Lupus Erythematosus
Inflammatory Arthritis
Sjogren's Syndrome 

Patient Stories

Videos

Insurance

If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Credentials

Appointments

Director, Scleroderma and Vasculitis Program, Hospital for Special Surgery
Attending Rheumatologist, Hospital for Special Surgery
Professor of Clinical Medicine, Weill Cornell Medical College
Attending Physician, NewYork-Presbyterian Hospital, Weill Cornell Medical Center

Affiliations

Fellow, American College of Rheumatology
Fellow, American College of Physicians
Member, American Medical Association
Chairman, Scleroderma Foundation Tri State Chapter Medical Advisory Board
Member, Vasculitis Foundation Scientific Advisory Board
Member of Medical Advisory Board, Scleroderma Foundation (National)
Member, Subcommittee Research, Scleroderma Foundation Tri-State

Certification

Rheumatology
Internal Medicine

Awards

Castle Connolly Top Doctors in New York Metro Area, 2021, 2022
New York Magazine Top Doctors, 2021, 2022
Emmanuel Rudd, M.D. and Martin Gardy, M.D. Best Rheumatology Fellow Teacher Award, 2006
Founders Award Recipient for Clinical Investigation – Scleroderma Foundation, 2005
The Globus Award (Outstanding article in Mount Sinai Journal of Medicine) – Mount Sinai School of Medicine, 1998

Education

MD, Yale University School of Medicine, New Haven, CT, 1989
Residency: Internal Medicine, NY Hospital, New York, NY, 1989-1992
Fellowship: Rheumatology, Hospital for Special Surgery, NY, 1992-1995

State Licensure

Languages

English, Spoken by Office Staff: Spanish, French

Publications by Dr. Spiera

Selected Journal Articles

Selected Books/Chapters

  • Spiera RF, Kagen LJ. Collagen vascular diseases: Polymyositis, dermatomyositis, and inclusion body myositis. In: Therapy of Systemic Rheumatic Disorders (eds, Furst D, van Riel P, Williams J), Marcell Decker, Inc,. New York, NY, 1998.

  • Spiera RF. Systemic Sclerosis and related disorders. In: Manual of Rheumatology and outpatient orthopedic disorders. (eds, Paget S, Gibofsky A, Pellici P), Little Brown and Co., Boston, 2000.

  • Spiera RF. Hyperlipoproteinemia and arthritis. In: Primer on the Rheumatic Diseases, 12th edition. (eds, Klippel J, Crawford L, Stone J, Weyand C), Atlanta: Arthritis Foundation, 2001.

  • Spiera RF. Polymyalgia Rheumatica, Giant Cell Arteritis and Takayasu's Arteritis. In: Expert Guide to Rheumatology. (eds, Yee AMF, Paget SA), Am College of Physicians, Phil, PA, 2005.

  • Spiera RF, Spiera, H. How Can I Be Sure It Is Really Sjögren's? The NewSjögren's Syndrome Handbook, 3rd edition. (ed Wallace DJ), Oxford University Press,Inc., New York, NY, 2005.

  • Paget SP, Spiera RF. Polymyalgia Rheumatica and Temporal Arteritis . In: Cecil's Textbook of Medicine, 23d edition, (eds, Goldman L, Ausiello D), Saunders, an imprint of Elsevier Inc., 2007 (292), 2059-2062.

  • Paget SP, Spiera RF. Polymyalgia Rheumatica In: Clinical Care in the Rheumatic Diseases, 3rd edition, (24), 153-157.

  • Spiera RF, Paget SP, Polymyalgia Rheumatica and Temporal Arteritis . In: Cecil's Textbook of Medicine, 24th edition 2010

  • Spiera RF, Spiera, H. "Why is Sjögren's so hard to diagnose?" The Sjögren's Syndrome Handbook, 4th edition. (ed Wallace DJ), Oxford University Press,Inc., New York, NY, 2010

Research

Clinical Trials / Research Studies

Patient Registries

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

Below are the healthcare industry relationships reported by Dr. Spiera as of February 16, 2024.

  • Abbvie, Inc. - Consultant; Research Support
  • Amgen, Inc. - Consultant
  • AstraZeneca - Research Support
  • BIPI - Research Support
  • Boehringer Ingelheim - Consultant
  • ChemoCentryx, Inc. - Advisory Board; Research Support
  • Chemomab - Consultant
  • Corbus Pharmaceuticals - Research Support
  • Formation Biologics - Consultant; Research Support
  • Galderma - Consultant
  • Genentech/Roche - Consultant; Research Support
  • GlaxoSmithKline - Advisory Board; Research Support
  • Horizon Therapeutics - Research Support
  • Kadmon Pharmaceuticals Corporation, LLC (formerly Kadmon Phamaceuticals) - Research Support
  • Medscape - Consultant
  • Novartis - Consultant; Research Support
  • Principia - Research Support
  • Regeneron Pharmaceuticals, Inc. - Consultant
  • Sanofi Adventis - Consultant
  • Veratx - Consultant

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.

Patients should feel free to ask their HSS physicians questions about these relationships.

Dr. Spiera in the News